Slfn3 inhibitors are a specialized class of chemical compounds designed to target and inhibit the function of the Schlafen family member 3 (Slfn3) protein. Slfn3 is part of the Schlafen (Slfn) family of proteins, which are involved in the regulation of various cellular processes, including cell differentiation, proliferation, and immune responses. Slfn3, in particular, has been implicated in the modulation of cell growth and the regulation of gene expression. By inhibiting Slfn3, researchers can study the effects of disrupted Slfn3 activity on these cellular processes, providing insights into the protein's role in cellular regulation and its broader implications in biological research.
The use of Slfn3 inhibitors in scientific studies allows for a deeper understanding of the molecular pathways influenced by this protein. Researchers utilize these inhibitors to investigate how Slfn3 impacts cell signaling pathways, gene transcription, and the cellular response to environmental stimuli. Inhibition of Slfn3 can lead to changes in the expression of downstream target genes, offering valuable information on the regulatory networks in which Slfn3 is involved. Additionally, Slfn3 inhibitors serve as tools to explore the interactions between Slfn3 and other proteins within the cell, shedding light on the protein's role in maintaining cellular homeostasis. By dissecting these pathways, scientists can gain a better understanding of the complex mechanisms that govern cell behavior and the intricate balance of cellular functions influenced by Slfn3 activity.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | ¥699.00 ¥1749.00 ¥3610.00 | 233 | |
Sirolimus forma un complejo con FKBP12 que inhibe mTOR, una quinasa implicada en la síntesis de proteínas, reduciendo posiblemente la expresión de la familia Schlafen (SLFN). | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | ¥1061.00 ¥3937.00 | 114 | |
Thapsigargin altera la homeostasis del calcio inhibiendo la ATPasa Ca2+ del retículo sarcoplásmico/endoplásmico, lo que podría reducir indirectamente la expresión de la familia Schlafen (SLFN). | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | ¥1907.00 ¥3373.00 | 66 | |
La tunicamicina inhibe la glicosilación ligada a N, lo que podría afectar a las proteínas implicadas en la regulación de la familia Schlafen (SLFN). | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | ¥609.00 | 6 | |
La mitramicina A se une al ADN e inhibe preferentemente la transcripción de las plantillas ricas en GC, que pueden incluir el gen de la familia Schlafen (SLFN). | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | ¥643.00 ¥2053.00 ¥1038.00 | 21 | |
La camptotequina inhibe la topoisomerasa I, lo que provoca daños en el ADN y puede afectar a la transcripción de la familia Schlafen (SLFN). | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | ¥733.00 ¥1117.00 ¥1579.00 | 85 | |
La mitomicina C entrecruza el ADN tras la activación reductora, lo que podría dificultar la transcripción del gen de la familia Schlafen (SLFN). | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | ¥824.00 ¥2685.00 ¥8089.00 ¥28453.00 ¥241660.00 | 53 | |
La actinomicina D se une al ADN e inhibe la elongación de la transcripción por la ARN polimerasa, lo que podría reducir la síntesis del ARNm de la familia Schlafen (SLFN). | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | ¥880.00 ¥2866.00 | 41 | |
El flavopiridol inhibe las quinasas dependientes de ciclinas y podría afectar a la expresión de la familia Schlafen (SLFN) relacionada con el ciclo celular. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | ¥301.00 ¥1128.00 | 257 | |
SP600125 es un inhibidor de JNK que puede alterar la actividad de los factores de transcripción, reduciendo posiblemente la expresión de la familia Schlafen (SLFN). | ||||||